All text is © British Library Board and is available under a Creative Commons Attribution Licence, except where otherwise stated.
Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
![]() |
Cancer incidence in Canadian prisonersBurki, Talha KhanThe Lancet oncology. Volume 18:Issue 4 (2017); pp e200- -- Elsevier ScienceOnline access |
2 |
Material Type: Article
|
![]() |
Correction to Lancet Oncol 2017; 18: 1221–37The Lancet oncology. Volume 19:Number 4 (2018, April); pp e184- -- Elsevier ScienceOnline access |
3 |
Material Type: Article
|
![]() |
Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysisConforti, Fabio et al.The Lancet oncology. Volume 19:Number 6 (2018, June); pp 737-746 -- Elsevier ScienceOnline access |
4 |
Material Type: Article
|
![]() |
Risk of gastrointestinal cancers in patients with cystic fibrosis: a systematic review and meta-analysisYamada, Akihiro et al.The Lancet oncology. Volume 19:Number 6 (2018, June); pp 758-767 -- Elsevier ScienceOnline access |
5 |
Material Type: Article
|
![]() |
Does a patient's sex predict the efficacy of cancer immunotherapy?Abdel-Rahman, OmarThe Lancet oncology. Volume 19:Number 6 (2018, June); pp 716-717 -- Elsevier ScienceOnline access |
6 |
Material Type: Article
|
![]() |
Targeting brain metastases in ALK-rearranged non-small-cell lung cancerZhang, Isabella et al.The Lancet oncology. Volume 16:Issue 13 (2015); pp e510-e521 -- Elsevier ScienceOnline access |
7 |
Material Type: Article
|
![]() |
Biomarkers for outcome upon MAPK inhibition in melanomaBlank, ChristianThe Lancet oncology. Volume 17:Issue 12 (2016); pp 1634-1636 -- Elsevier ScienceOnline access |
8 |
Material Type: Article
|
![]() |
Beyond a moonshot: insurance coverage for proton therapyShah, Anand; Ricci, Kelsey I; Efstathiou, Jason AThe Lancet oncology. Volume 17:Issue 5 (2016); pp 559-561 -- Elsevier ScienceOnline access |
9 |
Material Type: Article
|
![]() |
Neratinib after trastuzumab in patients with HER2-positive breast cancer – Author's replyChan, Arlene; Buyse, Marc; Yao, BinThe Lancet oncology. Volume 17:Issue 5 (2016); pp e176-e177 -- Elsevier ScienceOnline access |
10 |
Material Type: Article
|
![]() |
The metamorphosis of cancer careSwain, KelleyThe Lancet oncology. Volume 17:Issue 5 (2016); pp 563- -- Elsevier ScienceOnline access |